Med Student Medical News about Defibrillators, Implantable

Victoria Luken
Need answers to your point-of-care questions about type 2 diabetes?

D Scott Cunningham MD, PhD
The Best of 2009

See All Messages (2 new messages)

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial Infarction
JACC - Journal of the American College of Cardiology, 11/25/09

Goldberger JJ et al. – The risk of sudden death is highest early after myocardial infarction (MI) and progressively declines over the ensuing 6 to 12 months. Nevertheless, several randomized clinical trials have failed to show a survival benefit for implantable cardioverter–defibrillators when implanted early after MI in high–risk patients. The etiology of this acute MI–sudden cardiac death paradox is unclear, but may be related to the changing nature of the substrate over the several month period after acute MI. Further investigation is needed to delineate the actual causes of death in the early post–MI period and which interventions can be implemented to reduce the increased rate of sudden death that is observed.

<< Previous
Intravenous Drug Administration During Out-of-Hospital Cardiac...

Next >>
Association of Hospital Primary Angioplasty Volume in ST-Segment...